Illumina's competitors

Illumina's competitors include Perlara, Lexicon Pharmaceuticals, Sarepta Therapeutics and Vical
Add company...
Illumina
Illumina is a global company that develops innovative array-based solutions for DNA, RNA, and protein analysis.
Perlara
Perlara, PBC is a biotech startup and Public Benefit Corporation based in the Bay Area that is on a mission to discover personalized cures for diseases rare and common.
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.
Sarepta Therapeutics
Sarepta Therapeutics is a biopharmaceutical company focused on developing innovative RNA-targeted therapeutics.
Vical
Vical researches and develops biopharmaceutical products based on its patented DNA delivery technologies.
Founding Date
Founding Date
1998
Founding Date
2013
Founding Date
1995
Founding Date
1980
Founding Date
1987
Type
Type
Public
Type
Private
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
San Diego, US HQ
Scoresby, AU
São Paulo, BR
Victoria, CA
Shanghai, CN
Beijing, CN
Minato, JP
see more
Locations
San Francisco, US HQ
Locations
Spring, US HQ
Jersey, JE
Indianapolis, US
The Woodlands, US
Boston, US
Chicago, US
Philadelphia, US
see more
Locations
Cambridge, US HQ
Locations
San Diego, US HQ
Employees
Employees
5,500
Employees
3
Employees
168
Employees
197
Employees
73
Valuation ($)
Valuation ($)
31 b
Valuation ($)
N/A
Valuation ($)
1 b
Valuation ($)
3.4 b
Valuation ($)
21.9 m
Facebook followers
Facebook followers
12.1 k
Facebook followers
374
Facebook followers
N/A
Facebook followers
N/A
Facebook followers
N/A
Twitter followers
Twitter followers
49.5 k
Twitter followers
2.8 k
Twitter followers
97
Twitter followers
150
Twitter followers
62

Financial

Revenue (est.)
Revenue (est.)
$2.4b (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
$83.3m (FY, 2016)
Revenue (est.)
$5.4m (FY, 2016)
Revenue (est.)
$14.5m (FY, 2016)
Cost of goods
Cost of goods
$731.9m (FY, 2017)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$130k (FY, 2016)
Cost of goods
N/A
Gross profit
Gross profit
$1.7b (FY, 2017)
Gross profit
N/A
Gross profit
N/A
Gross profit
$5.3m (FY, 2016)
Gross profit
N/A
Net income
Net income
$428.1m (FY, 2017)
Net income
N/A
Net income
($141.4m) (FY, 2016)
Net income
($267.3m) (FY, 2016)
Net income
($9m) (FY, 2016)
For sources of this data, please see the company profileDownload Excel

View company profiles